[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Basic information
- Product Name:
- [D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
- Synonyms:
-
- H-HIS-SER-ASP-ALA-VAL-D-PHE(4-CL)-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-LEU-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
- HIS-SER-ASP-ALA-VAL-PCL-D-PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-LEU-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
- (D-PHE(4-CL)6,LEU17)-VIP (HUMAN,BOVINE, PORCINE, RAT)
- [D-P-CL-PHE6,LEU17]-VASOACTIVE INTESTINAL PEPTIDE
- [D-P-CL-PHE6,LEU17]-VASOACTIVE INTESTINAL PEPTIDE HUMAN
- [D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
- (D-P-CL-PHE6,LEU17)-VASOACTIVE*INTESTINA L PEPTIDE H
- [d-p-cl-phe6,leu17]-vasoactiveintestinalpeptidefromprocine
- CAS:
- 102805-45-8
- MF:
- C148H239ClN44O42
- MW:
- 3342.2
- Mol File:
- 102805-45-8.mol
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Chemical Properties
- Density
- 1.47±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- form
- Powder
- Water Solubility
- Soluble to 1 mg/ml in water
- Sequence
- His-Ser-Asp-Ala-Val-{Cl-Phe}-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Leu-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
MSDS
- Language:English Provider:SigmaAldrich
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Usage And Synthesis
Uses
[D-p-Cl-Phe6,Leu17]-VIP is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor, with the IC50 of 125.8 nM. [D-p-Cl-Phe6,Leu17]-VIP has no activity on glucagon, secretin or GRF receptors[1][2][3].
Biochem/physiol Actions
VIP receptor antagonist
storage
Store at -20°C
References
[1] Pozo D, et, al. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages. Eur J Pharmacol. 1997 Mar 5; 321(3): 379-86. DOI:10.1016/s0014-2999(96)00966-1
[2] Pandol SJ, et, al. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol. 1986 Apr; 250 (4 Pt 1): G553-7. DOI:10.1152/ajpgi.1986.250.4.G553
[3] Messmer B, et, al. Regulation of exocrine pancreatic secretion by cerebral TRH and CGRP: role of VIP, muscarinic, and adrenergic pathways. Am J Physiol. 1993 Feb; 264(2 Pt 1): G237-42. DOI:10.1152/ajpgi.1993.264.2.G237
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RATSupplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 0731-85526065 13308475853
- ivy@hnhbsj.com
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT(102805-45-8)Related Product Information
- H-VAL-NH2 HCL
- (R)-HOMO-BETA-ALANINE HYDROCHLORIDE
- H-GLY-PHE-NH2 HCL
- L-Serinamide hydrochloride
- H-ILE-NH2 HCL
- H-THR-NH2 HCL
- Aviptadil
- H-TYR-GLY-NH2 HCL
- DL-NORLEUCINE AMIDE HYDROCHLORIDE
- H-TYR-NH2 HCL
- D-ASPARTIC ACID ALPHA-AMIDE HYDROCHLORIDE
- H-NLE-NH2 HCL
- 1-(N-ACETYLAMINO)-2-(4-CHLOROPHENYL)-ETHANE
- H-ALA-PHE-NH2 HCL
- AC-LYS-NH2 HCL
- H-ASN-NH2 HCL
- H-THR-NHME HCL
- H-LEU-ALA-NH2 HCL